´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ 44th Korean College of Rheumatolgy Annual Scientific Meeting and the 18th International Symposium (KCR2024)-¼Â°³¯ : 2024-05-18
±³À°ÀÏÀÚ : 2024-05-18
±³À°Àå¼Ò : ÄÜ·¡µå ¼¿ï
±³À°ÁÖÁ¦ : (¿Â.¿ÀÇÁ º´Çà) 44th Korean College of Rheumatolgy Annual Scientific Meeting and the 18th International Symposium (KCR2024)-¼Â°³¯
ÁÖÃÖ±â°ü : ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ
´ã´çÀÚ : ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ
¿¬¶ôó : 02-794-2630
À̸ÞÀÏ : webmaster@rheum.or.kr
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Á¤Çü¿Ü°ú, ¿µ»óÀÇÇаú, ÀçÈ°ÀÇÇаú, °¡Á¤ÀÇÇаú
Âü¼®¿¹»óÀÎ : 1000¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 13 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 250,000¿ø
ºñ°í "»çÀüµî·Ï ȸ¿ø Àü¹®ÀÇ ÀüÀÓÀÇ 180,000¿ø, ºñȸ¿ø Àü¹®ÀÇ ÀüÀÓÀÇ 230,000¿ø
ÇöÀåµî·Ï ȸ¿ø Àü¹®ÀÇ ÀüÀÓÀÇ 200,000¿ø, ºñȸ¿ø Àü¹®ÀÇ ÀüÀÓÀÇ 250,000¿ø"
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05¿ù 18ÀÏ Room 1 08:00~08:40 Role of SIMPONI in Treatment Sequencing for Patients with axSpA ÀÌ°æ¾ð(¼øõÇâ´ëÇб³)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 1 09:00~10:00 ESG in Healthcare: Role of Academic Society ±è±¤Á¡(°¡Å縯´ëÇб³)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 1 10:30~11:00 ASAS Consensus Definition of Early Axial Spondyloarthritis Sofia Ramiro(Leiden Univ. Medical Center, Netherlands)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 1 11:00~11:30 Radiologic Findings of Early Axial Spondyloarthirits À̽ÂÈÆ(ÇѾç´ëÇб³)
Åä·Ð 05¿ù 18ÀÏ Room 1 11:30~12:00 Discussion ()
±³À°½Ã°£ 05¿ù 18ÀÏ Room 1 12:00~12:40 What Impact May Arise from the Early-stage Inhibition of IL-17A in AS? ±èÅÂÁ¾(Àü³²´ëÇб³)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 1 13:00~13:30 Novel Mechanisms and Emerging Therapeutic Targets for OA Frank Beier(Western Univ., Canada)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 1 13:30~14:00 CAR-T Cell Therapy in Systemic Lupus Erythematosus Georg Schett(Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany)
Åä·Ð 05¿ù 18ÀÏ Room 1 14:00~14:30 Discussion ()
±³À°½Ã°£ 05¿ù 18ÀÏ Room 2 08:00~08:40 Advanced Treatment Options for AS: How to Choose? ¹®¼öÁø(°¡Å縯´ëÇб³)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 2 10:30~10:40 (±¸¿¬ ¹ßÇ¥) Comparative effectiveness of subcutaneous sarilumab, subcutaneous tocilizumab, and intravenous tocilizumab in patients with rheumatoid arthritis: the ANSWER cohort study Akira Onishi (Kyoto Univ. Graduate School of Medicine, Japan)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 2 10:40~10:50 (±¸¿¬ ¹ßÇ¥) Real-world comparative effectiveness study of Janus Kinase inhibitors compared to biologic disease modifying antirheumatic drugs in Korean patients with rheumatoid arthritis Á¶¼ö°æ(ÇѾç´ëÇб³)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 2 10:50~11:00 (±¸¿¬ ¹ßÇ¥) Effectiveness of tumor necrosis factor inhibitors in combination with MTX or non-MTX csDMARDs in patients with rheumatoid arthritis: Data from the KOBIO registry ±è¹ÎÁ¤(¼¿ï´ëÇб³)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 2 11:00~11:10 (±¸¿¬ ¹ßÇ¥) Influence of fat mass and sarcopenia on treatment response of targeted therapy in rheumatoid arthritis: A single-center prospective study ±èÁö¿ø(°¡Å縯´ëÇб³)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 2 11:10~11:20 (±¸¿¬ ¹ßÇ¥) Predicting methotrexate response in early rheumatoid arthritis using machine learning analysis of joint ultrasound imaging Rifaldy Fajar(Karlstad Univ., Sweden)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 2 11:20~11:30 (±¸¿¬ ¹ßÇ¥) Increased risk of cancer in patients with systemic sclerosis: A population-based study Àº¿µÈñ (¼º±Õ°ü´ëÇб³)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 2 11:30~11:40 (±¸¿¬ ¹ßÇ¥) Cancer incidence and impact of immunosuppressive agents in Korean systemic lupus erythematosus patients ÇÑÁ¤¿ë (ÇѾç´ëÇб³)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 2 11:40~11:50 (±¸¿¬ ¹ßÇ¥) Risk of gynecologic cancer among Korean women of childbearing age with rheumatic diseases ÀÌÁö¼ö(ÀÌÈ¿©´ë)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 2 11:50~12:00 (±¸¿¬ ¹ßÇ¥) Long-term cancer risk of tumor necrosis factor inhibitors in ankylosing spondylitis: A single-center cohort study ÀÌ¿©Áø (¿ï»ê´ëÇб³)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 2 12:00~12:40 Putting the Patient First : The Value of SHINGRIX for Rheumatologic Patient ¹Ú¿µÀç(°¡Å縯´ëÇб³)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 2 13:00~13:30 Clinical and Laboratory Approach to Juvenile Idiopathic Arthritis ±è¿µ´ë(Inje Univ., Korea)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 2 13:30~14:00 Juvenile Dermatomyositis; Updates ÀÓÁ¤¿ì(°¡Å縯´ëÇб³)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 2 14:00~14:30 Advances in Still's Disease (systemic JIA, AOSD) ±èÇö¾Æ(¾ÆÁÖ´ëÇб³)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 3 08:00~08:40 Treatment Option (Adalimumab) for RA patients ±èÇö¾Æ(¾ÆÁÖ´ëÇб³)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 3 10:30~10:40 (±¸¿¬ ¹ßÇ¥) Association of rheumatoid arthritis with age-related macular degeneration: A nationwide cohort study Àº¿µÈñ(¼º±Õ°ü´ëÇб³)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 3 10:40~10:50 (±¸¿¬ ¹ßÇ¥) The status of baseline screening ophthalmologic examinations in patients with rheumatic diseases starting hydroxychloroquine using Health Insurance Review and Assessment Service database ±è¾Æ¶õ(ºÎ»ê´ëÇб³)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 3 10:50~11:00 (±¸¿¬ ¹ßÇ¥) Prevalence and risk factors of non-alcoholic fatty liver disease in patients with rheumatoid arthritis: a nationwide population-based study Shiyu Xiao(Sichuan Academy of Medical Science and Sichuan Provincial People)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 3 11:00~11:10 (±¸¿¬ ¹ßÇ¥) Infertility and the chance of successful assisted assisted reproductive therapy in childbearing women with rheumatic diseases Á¤¹Î°æ(ÀÌÈ¿©´ë)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 3 11:20~11:30 (±¸¿¬ ¹ßÇ¥) Pregnancy risk and undifferentiated connective tissue disease Fangning You(Chongqing Hosp. of Traditional Chinese Medicine, China)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 3 11:30~11:40 (±¸¿¬ ¹ßÇ¥) A novel scoring system to predict serious infections in patients with rheumatic diseases receiving prolonged, high-dose glucocorticoid treatment ÃÖ¼¼¸²(¼¿ï´ëÇб³)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 3 11:40~11:50 (±¸¿¬ ¹ßÇ¥) Incidence of systemic vasculitides after Mycobacterium tuberculosis infection: A population-based cohort study in Korea ¾È¼º¼ö(¿¬¼¼´ëÇб³)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 3 11:50~12:00 (±¸¿¬ ¹ßÇ¥) Human papillomavirus vaccination awareness in Chinese autoimmune inflammatory rheumatic diseases: a large real-world survey Juan Zhao(Peking Univ. First Hosp., China)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 3 12:00~12:40 What Remission Means to Patients Versus to HCPs: Closing the Gap with Rinvoq õÀ±È« (°æ»ó´ëÇб³)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 3 13:00~13:10 (±¸¿¬ ¹ßÇ¥) Utility of a multi-biomarkers panel on predicting disease activity in patients with psoriatic arthritis – a derivation and validation study Yingzhao Jin(Hong Kong, The Chinese Univ. of Hong Kong, Hong Kong)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 3 13:10~13:20 (±¸¿¬ ¹ßÇ¥) Using RNA-Seq data of TgA86 mouse model of spondyloarthritis ±è¼¼Èñ(°æÈñ´ëÇб³)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 3 13:20~13:30 (±¸¿¬ ¹ßÇ¥) Aortic inflammation and Wnt signaling undergo activation in the context of spondyloarthritis in the HLA-B27 transgenic rat model ±Ç¼º·Ä(ÀÎÇÏ´ëÇб³ )
±³À°½Ã°£ 05¿ù 18ÀÏ Room 3 13:30~13:50 ·ù¸¶Æ¼½º³»°ú Àǻ簡 »ý°¢ÇÏ´Â ÇʼöÀÇ·áÀÇ Á¤ÀÇ À±º¸¿µ(ÀÎÁ¦´ëÇб³)
±³À°½Ã°£ 05¿ù 18ÀÏ Room 3 13:50~14:10 ·ù¸¶Æ¼½ºÁúȯÀÇ Áø·á ¼ö¿ä¿Í º´¿øº° ¿ªÇÒ, ±×¸®°í±³À°ÇÁ·Î±×·¥ °³ÆíÀÇ Çʿ伺 ±è±ÙÅÂ(°í½Å´ëÇб³)
Åä·Ð 05¿ù 18ÀÏ Room 3 14:10~14:30 Panel Discussion ()